European Archives - Page 601 of 1279 - European Medical Journal

Haematopoietic Stem Cell Transplant (HSCT) in Diffuse Cutaneous Systemic Sclerosis (dcSSc) and Potential Role of FCR001, an Investigational Allogeneic Cell Therapy

This podcast explores hematopoietic stem cell transplant in diffuse cutaneous systemic sclerosis (dcSSc) and the potential role of FCR001, an investigational allogeneic cell therapy. We are pleased to be joined by leading scleroderma expert Dinesh Khanna MD, MSc.

Cepheid: Working Together to Bring Better Patient Testing Everywhere

Learn how PCRplus is simplifying access to powerful lab quality tests and delivering more than results. Watch now!

The Future of Heart Failure: LVAD

In this short interview, Finn Gustafsson explains how an LVAD works, and when patient referral to a specialised centre should be considered

Inspiring innovation and the future of digital therapeutics

Helena and Jade introduce a discussion on the future of digital therapeutics with Eugene Borukhovich, Co-Founder and COO, YourCoach.Health.

Prosigna on demand webinars

Interactive webinar designed for doctors treating breast cancer interested in advancing personalized treatment through molecular gene expression testing.

The Emerging Role of Homologous Recombination Deficiency Testing and the Progress of PARP Inhibitors in Advanced Ovarian Cancer: Interviews with Three Key Opinion Leaders

Ovarian cancer is the most lethal gynaecologic malignancy worldwide because of its vague presentation, insidious nature, recurrence, and drug resistance.

EMJ Oncology 10 [Supplement 10] 2022

In this article, EMJ conducted interviews with three experts in the field of ovarian cancer, Ram Ganapathi, Department of Obstetrics and Gynecology, Women’s Health Institute, Cleveland Clinic, Ohio, USA; Mansoor Raza Mirza, Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Denmark; and Rowan Miller, University College London Hospitals NHS Foundation Trust, UK.

Good Versus Bad: A Medical Discussion

Jonathan and William Barrett talk about the vilification of fats and how social media can be used as a way of altering HCPs when new research is available.

Daiichi Sankyo's Mary Pinder-Schenck on oncology innovation

Daiichi Sankyo’s Mary Pinder-Schenck speaks about the evolution she has witnessed in oncology throughout her career and what she predicts for the future of the field.

The Rise of Anti-TNF Biosimilars: Guidelines, Real-World Evidence, and Challenges to Acceptance

The over-production of TNF-α can lead to chronic inflammation and organ damage in immune-mediated inflammatory diseases (IMID), such as rheumatoid arthritis (RA), axial spondyloarthritis, psoriasis, and inflammatory bowel disease (IBD). Anti-TNF therapy is generally considered to be an effective, well-tolerated treatment option for the management of chronic inflammation in these conditions.